Reference
Van Keer JM, et al. Idarucizumab for the reversal of dabigatran in patients undergoing heart transplantation. European Journal of Heart Failure 21: 129-131, No. 1, Jan 2019. Available from: URL: http://doi.org/10.1002/ejhf.1356 -Belgium
Rights and permissions
About this article
Cite this article
Aspirin/dabigatran etexilate/heparin. Reactions Weekly 1742, 43 (2019). https://doi.org/10.1007/s40278-019-58501-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-58501-z